Prognostic significance of anatomical resection and des-γ-carboxy prothrombin in patients with hepatocellular carcinoma

British Journal of Surgery

Volumn 86, Issue 8, 1999, Pages 1032-1038

  Imamura, H ^c   Matsuyama, Y ^b   Miyagawa, Y ^a   Ishida, K ^a   Shimada, R ^a   Miyagawa, S ^a   Makuuchi, M ^c   Kawasaki, S ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BLOOD CLOTTING FACTOR; DECARBOXYPROTHROMBIN;

ACCURACY; ARTICLE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PORTAL VEIN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; TUMOR VOLUME;

BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN PRECURSORS; PROTHROMBIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0032784523     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01185.x     Document Type: Article

References (36)

1. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference. Hepatocellular carcinoma. Ann Intern Med 1988; 108: 390-401.
2. Arii S, Okamoto E, Imamura M. Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan. Semin Surg Oncol 1996; 12: 204-11.
3. Kobayashi K, Sugimoto T, Makino H, Kumagai M, Unoura M, Tanaka N et al. Screening methods for early detection of hepatocellular carcinoma. Hepatalogy 1985; 5: 1100-5.
4. Makuuchi M, Hasegawa H, Yamazaki S, Takayasu K, Moriyama N. The use of operative ultrasound as an aid to liver resection in patients with hepatocellular carcinoma. World J Surg 1987; 11: 615-21.
5. Lin TY, Lee CS, Chen KM, Chen CC. Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience. Br J Surg 1987; 74: 839-42.
6. Kanematsu T, Matsumata T, Takenaka K, Yoshida Y, Higashi H, Sugimachi K. Clinical management of recurrent hepatocellular carcinoma after primary resection. Br J Surg 1988; 75: 203-6.
7. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T et al. Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990; 65: 1104-10.
8. Franco D, Capussotti L, Smadja C, Bouzari H, Meakins J, Kemeny F et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 1990; 98: 733-8.
9. Arii S, Tanaka J, Yamazoe Y, Minematsu S, Morino T, Fujita K et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992; 69: 913-19.
10. Chen MF, Hwang TL, Jeng LB, Jan YY, Wang CS, Chou FF. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 1989; 124: 1025-8.
11. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16: 1367-71.
12. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 1993; 40: 328-32.
13. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106: 1618-24.
14. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169: 28-34.
15. Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma. Cancer 1996; 78: 2094-100.
16. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994; 106: 720-7.
17. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161: 346-50.
18. Yamamoto J, Kosuge T, Takayama K, Shimada S, Yamasaki H, Ozaki N et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996; 83: 1219-22.
19. Fuster J, García-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 1996; 223: 297-302.
20. Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984; 310: 1427-31.
21. Inoue S, Nakao A, Harada A, Nonami T, Takagi H. Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma. Am J Gastroenterol 1994; 89: 2222-6.
22. Sakon M, Monden M, Gotoh M, Kanai T, Umeshita K, Nakano Y et al. Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma. Am J Surg 1992; 163: 251-6.
23. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S et al. Surgery for small liver cancers. Semin Surg Oncol 1993; 9: 298-304.
24. Healey JE Jr, Schroy PC. Anatomy of the biliary ducts within the human liver. Analysis of the prevaiing pattern of branchings and the major variations of the biliary ducts. Arch Surg 1953; 66: 599-616.
25. Couinaud C. Le Foie. Etudes Anatomiques et Chirurgicales. Paris: Masson, 1957.
26. The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan. Japanese Journal of Surgery 1989; 19: 98-129.
27. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48 900 necropsies. Cancer 1954; 7: 462-503.
28. Cox D, Oakes D. Analysis of Survival Data. London: Chapman and Hall, 1983.
29. Schlichting P, Christensen E, Andersen PK, Fauerholdt L, Juhl E, Poulsen H et al. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 1983; 3: 889-95.
30. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
31. SAS Institute. SAS/Stat User's Guide. Version 6. Cary, North Carolina: SAS Institute, 1990: 433-9.
32. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov B, Csaki H, eds. Second International Symposium on Information Theory. Budapest: Akademiai Kaido, 1973: 267-81.
33. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214: 114-17.
34. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987; 205: 33-40.
35. Nakashima T, Kojiro M. Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis 1986; 6: 259-66.
36. Alpert E, Hershberg R, Schur PH, Isselbacher KJ. Alpha-fetoprotein in human hepatoma: improved detection in serum, and quantitative studies using a new sensitive technique. Gastroenterology 1971; 61: 137-43.